BioAtla
Patents, Design & Utilities
Last updated:
List of all BioAtla patents 14 in total
Status | Patent |
---|---|
Grant | Utility: Comprehensive monoclonal antibody generation Filling date: 26 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Utility: Express humanization of antibodies Filling date: 26 Sep 2025 Issue date: 26 Jul 2022 |
Application | Utility: ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUCATES AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: CONDITIONALLY ACTIVE BIOLOGICAL PROTEINS Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: CONDITIONALLY ACTIVE POLYPEPTIDES AND METHODS OF GENERATING THEM Filling date: 26 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTI-AXL ANTIBODIES, ANTIBODY FRAGMENTS AND THEIR IMMUNOCONJUGATES AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: ANTI-CTLA4 Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS Filling date: 26 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: CONDITIONALLY ACTIVE PROTEINS WITH pH SELECTIVITY Filling date: 26 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: MULTI-SPECIFIC ANTIBODY CONSTRUCTS Filling date: 26 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: Anti-Il-22 Antibodies, Antibody Fragments,Their Immunoconjugates And Uses Thereof Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: SIMULTANEOUS, INTEGRATED SELECTION AND EVOLUTION OF ANTIBODY/PROTEIN PERFORMANCE AND EXPRESSION IN PRODUCTION HOSTS Filling date: 26 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: NOVEL METHODS OF PROTEIN EVOLUTION Filling date: 26 Sep 2025 Issue date: 21 Jan 2021 |
Showing 1 to 14 of 14 patents.